A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1999
12/23/1999	CA2331154A1 Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
12/23/1999	CA2331151A1 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999	CA2330939A1 Variant type ii tgf-beta receptor fusion proteins and methods
12/23/1999	CA2330824A1 Hla binding peptides and their uses
12/23/1999	CA2330544A1 A novel gene and method of treating a gram negative bacterial infection
12/23/1999	CA2330527A1 Erythropoietin analog-human serum albumin fusion
12/23/1999	CA2330228A1 Angiostatin-binding protein
12/23/1999	CA2330210A1 Proteasomal activity
12/23/1999	CA2330209A1 Recombinant production of toxoplasma sag1 antigen
12/23/1999	CA2329689A1 Composition and method for treatment of pseudomonas
12/22/1999	EP0965640A1 GP75 as a tumor vaccine for melanoma
12/22/1999	EP0965639A1 Attenuated pestiviruses
12/22/1999	EP0965638A2 G-CSF analog compositions and methods
12/22/1999	EP0965637A1 Fas ANTIGEN DERIVATIVES
12/22/1999	EP0965597A1 Cell membrane-directed drugs
12/22/1999	EP0965596A1 Method for elevating the concentration of free insulin-like growth factor
12/22/1999	EP0965595A1 Protein complex
12/22/1999	EP0965594A2 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein
12/22/1999	EP0965583A1 Polyamine compounds and compositions containing them useful for the transfer of active substances into a cell
12/22/1999	EP0965351A2 Pharmaceutical composition for treating side-effects of a diet with reduced amount of carbohydrates
12/22/1999	EP0965349A1 Use of erythropoietin for the treatment of hemochromatosis
12/22/1999	EP0965278A1 Dietetic food composition and dietetic method using such composition
12/22/1999	EP0964930A1 Catalytic rna molecules
12/22/1999	EP0964925A2 A basal cell carcinoma tumor suppressor gene
12/22/1999	EP0964922A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection
12/22/1999	EP0964921A1 Novel streptococcal ers
12/22/1999	EP0964874A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof
12/22/1999	EP0964873A1 Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery
12/22/1999	EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/22/1999	EP0964869A1 Methods and compositions for generating angiostatin
12/22/1999	EP0964868A1 Isolated peptides derived from mage-2
12/22/1999	EP0964867A2 Tachykinin antagonists
12/22/1999	EP0964697A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
12/22/1999	EP0964695A1 Methods and compositions for treating pain
12/22/1999	EP0964694A1 Mucin-mediated immunomodulation
12/22/1999	EP0964693A1 Novel bacteriocins, transport and vector system and method of use thereof
12/22/1999	EP0964692A1 Use of glp-1 or analogs in treatment of myocardial infarction
12/22/1999	EP0964691A1 Use of conantokins
12/22/1999	EP0964690A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
12/22/1999	EP0964686A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions
12/22/1999	EP0964617A1 Structure-based rational design of compounds to inhibit papillomavirus infection
12/22/1999	EP0923382A4 Compositions of plant carbohydrates as dietary supplements
12/22/1999	EP0910385A4 Sensitization of cells to radiation and chemotherapy
12/22/1999	EP0726954B1 Cytokine antagonists
12/22/1999	EP0711167A4 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict
12/22/1999	EP0661973A4 Method of preventing nmda receptor complex-mediated neuronal damage.
12/22/1999	EP0659083B1 Prevention and treatment of peripheral neuropathy
12/22/1999	EP0515386B1 Glycoalkaloids
12/22/1999	CN1239510A Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4)
12/22/1999	CN1239480A Pharmaceutical compsns. containing an MPL ligand
12/22/1999	CN1239436A Topical prepn. for introducing peptidaceous pharmacons in living organisms
12/22/1999	CN1239435A Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors
12/22/1999	CN1239434A Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors
12/22/1999	CN1239433A Methods and compsns. for stimulating neurite growth using compounds with affinity for PKBP12 in combination with neurotrophic factors
12/22/1999	CN1239432A Solid pharmaceutical compsns. comprising cyclosporin and anionic surfactant
12/22/1999	CN1239431A Immunogenic TLP compsn.
12/22/1999	CN1239429A Methods for minimizing bone loss
12/22/1999	CN1047517C Oral hygienic compsns.
12/21/1999	US6005095 Antisense agents; antitumor agents
12/21/1999	US6005091 Nucleic acids encoding immunoglobulin domains
12/21/1999	US6005090 Treatment and prevention of helicobacter infection
12/21/1999	US6005089 Nucleotide sequence which hybridizes to major platelet membrane protein; for diagnosis and gene therapy of related diseases; for detection of cells of megakaryoblastic lineage in humans
12/21/1999	US6005087 Nuclease resistant oligonucleotides which are useful as therapeutics, diagnostics, and research reagents for various viral diseases
12/21/1999	US6005082 Process for purification of factor VIII
12/21/1999	US6005080 Nucleotide sequences and expression vectors encoding hu-b1.219 gene product; molecular probes designed from its nucleotide sequence may be useful for prenatal testing and cancer diagnosis
12/21/1999	US6005078 Canine-derived hemoglobin blood substitute, the process for preparing same and uses thereof
12/21/1999	US6005077 Use of von willebrand factor and pharmaceutical formulation
12/21/1999	US6005075 Purification; use in antitumor and/or antiviral treatment
12/21/1999	US6005074 Cloning of human GPR14 receptor
12/21/1999	US6005071 Specific region of hirudin that is responsible, at least in part, for its anticoagulant activity
12/21/1999	US6005020 Bioresorbable compositions for implantable prostheses
12/21/1999	US6004972 Therapeutic process for the treatment of the pathologies of type II diabetes
12/21/1999	US6004962 Sedation with anesthetic, intubation, ventialation, paralyzing with neuromuscular blockin agent; detoxification, reviving, extubation; administering antagonist maintenance therapy
12/21/1999	US6004946 Administering 2-(hydroxyphosphinylmethyl)-pentanedioic acid derivatives; treating nervous system disorders
12/21/1999	US6004944 Protein delivery by secretory gland expression
12/21/1999	US6004942 Administering viral vector to joint comprising nucleic acid sequence encoding polypeptide; gene expression
12/21/1999	US6004940 Gene expression; nucleic acid segment encoding variable heavy chain sequence of antibody which selectively binds antigen
12/21/1999	US6004938 Inositolglycans having insulin-like action
12/21/1999	US6004937 Treating muscular and nervous system disorders
12/21/1999	US6004936 Potentiating release of macrophage cholesterol; treating atherosclerosis; complexing with high density lipoproteins
12/21/1999	US6004934 Tetrapeptide derivative
12/21/1999	US6004933 Cysteine protease inhibitors
12/21/1999	US6004932 Use of glucagon as a metabolic conditioner for dairy cows and other ruminants
12/21/1999	US6004931 Method for inhibiting growth hormone action
12/21/1999	US6004930 Administering gamma zein protein with phenylalanine amino acids removed; phenylketonuria treatment; eliminated codons
12/21/1999	US6004929 Biologically active PDGF A-chain homodimers
12/21/1999	US6004928 Method of treating hyperlipidemia
12/21/1999	US6004927 Coadministering bioenhancer comprising inhibior of cytochrome p450 3a or p-glycoprotein-mediated membrane transport
12/21/1999	US6004925 Polypeptide anticholesterol agents; cardiovascular disorders, restenosis, atherosclerosis
12/21/1999	US6004924 Protein sequences of serrate gene products
12/21/1999	US6004813 Il-6 activity inhibitor
12/21/1999	US6004812 In-vitro T-lymphopoiesis system
12/21/1999	US6004811 Isolated cytotoxic t-cell which expresses a membrane-bound chimeric receptor which binds target cell and signals to destroy bound target cell; targets infected, cancerous, tumor or autoimmune-generated cells
12/21/1999	US6004806 Optimized minizymes and miniribozymes and uses thereof
12/21/1999	US6004803 Genes encoding HSV1-TK containing a deletion of 5' cryptic promoter sites, vectors and cell lines
12/21/1999	US6004794 Human serine protease
12/21/1999	US6004792 Amino acid sequence of enzyme which controls intracellular lipids; for antiinflammatory/antiproliferative/ anticarcinogenic agents; diagnosis and prevention of autoimmune, gastrointestinal, and cardiovascular disorders
12/21/1999	US6004791 Amino acid sequence of polypeptide involved in controlling growth factor stimulation of cellular differentiation; for anticarcinogenic agnents and treatment of neural injuries
12/21/1999	US6004778 Amino acid sequence of a new human protein; for diagnosis, prevention, and treatment of disorders associated with cell proliferation and apoptosis; anticarcinogenic agents
12/21/1999	US6004775 DNA encoding IGFBP-4

1 ... 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 ... 3163